The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 20, 2021
Filed:
Nov. 02, 2016
Applicant:
Toray Industries, Inc., Tokyo, JP;
Inventors:
Atsuko Miyano, Kamakura, JP;
Hiroko Sudo, Kamakura, JP;
Aiko Takayama, Kamakura, JP;
Taiga Arai, Kamakura, JP;
Assignee:
TORAY INDUSTRIES, INC., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/04 (2006.01); A61K 31/7088 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); A61K 45/00 (2006.01); C12N 15/113 (2010.01); A61P 35/02 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01); A61K 45/00 (2013.01); A61K 48/00 (2013.01); A61P 35/02 (2018.01); C12N 15/113 (2013.01); A61K 45/06 (2013.01); C12N 2310/141 (2013.01); C12N 2320/30 (2013.01);
Abstract
The present application provides a pharmaceutical composition for treating and/or preventing a cancer comprising, as an active ingredient, a polynucleotide derived from miRNA associated with the cancer, a combination drug of the pharmaceutical composition and another antitumor agent, and a method for treating or preventing a cancer in a subject having the cancer using the pharmaceutical composition or the combination drug.